-

AscellaHealth Announces Strategic Global Joint Venture, Forming 4Merit Solutions

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global healthcare and specialty pharmacy (SP) solutions company, is proud to announce a strategic partnership with 4Merit, a dedicated provider of exceptional outsourced services to the UK government. This collaboration marks the formation of 4Merit Solutions, a global joint venture aimed at delivering comprehensive services and solutions to governments and public organizations around the world.

“This strategic collaboration brings together our collective strengths and expertise to establish a new enterprise that delivers innovative healthcare solutions aligned seamlessly with values-based government outsourcing,” says Dea Belazi, president and CEO, AscellaHealth. “4Merit Solutions reflects our shared commitment to providing unparalleled services to governments and public entities worldwide. Leveraging our combined capabilities will have a positive impact on the communities we serve.”

The synergy between these organizations allows 4Merit Solutions to pool resources, share knowledge, and collectively address the unique challenges faced by governments and public organizations.

“4Merit Solutions aspires to establish exemplary standards in delivering efficient, secure and transparent solutions across various industries and public service sectors, such as justice, immigration, health, transport and defense,” says Colin Dobell, CEO, 4Merit. “Our alignment with AscellaHealth allows us to tap into deep bench healthcare and pharmaceutical experience across various functions, to provide a wide range of healthcare services to governments and public entities.”

About AscellaHealth LLC

AscellaHealth, a global healthcare and specialty pharmacy solutions organization, serving patients, life sciences manufacturers, payers and providers, offers a comprehensive portfolio of uniquely tailored, tech-enabled services supporting complex, chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. A recipient of numerous industry awards for innovation, including Deloitte Technology Fast 500™ and Inc. 5000, AscellaHealth’s customized, patient-centric approach is built upon proprietary technology processes for end-to-end solutions to streamline the commercialization of specialty medications and proactively address unmet client needs, optimize clinical health outcomes and improve the quality of life for this patient population. AscellaHealth brings a rare and special perspective to all stakeholders. Visit www.AscellaHealth.com.

About 4Merit

Established in 2021, 4Merit is a dedicated provider of exceptional outsourced services to the UK government. 4Merit specializes in immigration services, secure care, protected transport, and security services, all driven by a public service ethos, delivering excellence to serve the greater public good. Our top-tier expertise and core values such as transparency, a passion for public service and commitment to social responsibility are at the foundation of all we do, creating a collaborative environment for all stakeholders to join in our success.

https://www.4merit.co.uk/

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Marketing:
Darcey McDermott, Chief Marketing & Communications Officer
AscellaHealth
darcey.mcdermott@ascellahealth.com
877.389.9040

AscellaHealth


Release Versions

Contacts

Media:
Nicole Dufour
CPR Communications
ndufour@cpronline.com
201.641.1911 x 54

Marketing:
Darcey McDermott, Chief Marketing & Communications Officer
AscellaHealth
darcey.mcdermott@ascellahealth.com
877.389.9040

Social Media Profiles
More News From AscellaHealth

AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Ranks Third on Philadelphia Business Journal’s 2024 Fast 50 List of Fastest-Growing Companies...

AscellaHealth Showcases End-to-End Specialty Pharmaceutical Commercialisation Solutions at World Orphan Drug Congress, Shapes Future of Rare and Orphan Disease Therapies

DUBLIN--(BUSINESS WIRE)--AscellaHealth, a global partner delivering customisable solutions for the specialty pharmaceutical industry, proudly announces its role as Gold Sponsor of the World Orphan Drug Congress Europe (WODC), 22-25 October 2024, Barcelona, Spain. During the event, AscellaHealth will exhibit its comprehensive suite of end-to-end solutions proven to streamline the specialty pharmaceutical commercialisation process for life science manufacturers worldwide. These solutions align wi...

AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Key Issues Impacting Life Sciences & Payers within the Specialty Healthcare Ecosystem

BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth Podcast Pulse: AscellaHealth Launches Podcast Series Addressing Issues Impacting Life Sciences & Payers within the Specialty Healthcare...
Back to Newsroom